Observational studyExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association2023

Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany.

Markus Menzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.